TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 25941995

Group type: EXPERIMENTAL
Intervention: Custom foot orthoses (CFO)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Prefabricated foot orthoses (PFO)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Sham insole treatment
Number of subjects: 77

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 77
Study: 23464600

Group type: EXPERIMENTAL
Intervention: Innovative program using concept mapping
Number of subjects: 150

Group type: COMPARATOR
Intervention: Traditional program
Number of subjects: 150
Study: 21316752

Group type: EXPERIMENTAL
Intervention: Candesartan (4 mg on day 1 to 16 mg on days 3 to 7)
Number of subjects: 2029

Group type: EXPERIMENTAL
Intervention: Candesartan
Number of subjects: 2029

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2029
Study: 18192330

Group type: EXPERIMENTAL
Intervention: LC Star jet nebuliser
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: LS 290 ultrasonic nebuliser
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Projet ultrasonic nebuliser
Number of subjects: 17
Study: 16445306

Group type: EXPERIMENTAL
Intervention: Rivastigmine 3-12 mg/day
Number of subjects: 541

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 541
Study: 14610122

Group type: EXPERIMENTAL
Intervention: Topiramate at low plasma level (6 micromol/L [2 mg/L])
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Topiramate at medium plasma level (31 micromol/L [10.5 mg/L])
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Topiramate at high plasma level (56 micromol/L [19 mg/L])
Number of subjects: 65

Group type: COMPARATOR
Intervention: Comparison of low vs medium plasma levels
Number of subjects: 65

Group type: COMPARATOR
Intervention: Comparison of medium vs high plasma levels
Number of subjects: 65

Group type: COMPARATOR
Intervention: Comparison of low vs high plasma levels
Number of subjects: 65
Study: 10696124

Group type: EXPERIMENTAL
Intervention: Preoperative chemotherapy leading to complete necrosis (CNWT)
Number of subjects: 599

Group type: EXPERIMENTAL
Intervention: Stages I-III patients with CNWT
Number of subjects: 599

Group type: EXPERIMENTAL
Intervention: Stage IV patients with CNWT
Number of subjects: 599

Group type: EXPERIMENTAL
Intervention: Wilms tumors of blastemic pattern
Number of subjects: 599

Group type: EXPERIMENTAL
Intervention: Wilms tumors with <10% viable tumor
Number of subjects: 599
Study: 8730245

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg b.d. plus amoxycillin 750 mg t.d.s. for 2 weeks
Number of subjects: 168

Group type: COMPARATOR
Intervention: Omeprazole 40 mg t.d.s. plus amoxycillin 750 mg t.d.s. for 2 weeks
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Retreatment in group I
Number of subjects: 168

Group type: COMPARATOR
Intervention: Retreatment in group II
Number of subjects: 168
Study: 1420747

Group type: EXPERIMENTAL
Intervention: High enzyme preparation ('Pancrease HL', Cilag)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard pancreatic enzyme supplement ('Creon', Duphar)
Number of subjects: 0
Study: 3838343

Group type: EXPERIMENTAL
Intervention: Cyclophosphamide (CTX)
Number of subjects: 31

Group type: COMPARATOR
Intervention: FAM' (5-fluorouracil, doxorubicin, mitomycin C)
Number of subjects: 31
Study: 28579349

Group type: EXPERIMENTAL
Intervention: Electromagnetic-guided placement (EMP)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Endoscopic-guided placement (EGDP)
Number of subjects: 155
Study: 26731179

Group type: EXPERIMENTAL
Intervention: UVCs
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: PICCs
Number of subjects: 104
Study: 25524399

Group type: EXPERIMENTAL
Intervention: Self‐determination Theory‐based intervention
Number of subjects: 0
Study: 23342791

Group type: EXPERIMENTAL
Intervention: External fixation
Number of subjects: 32

Group type: COMPARATOR
Intervention: Traction
Number of subjects: 32
Study: 19251828

Group type: EXPERIMENTAL
Intervention: Escitalopram 10 mg
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Escitalopram 20 mg
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study: 18363420

Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 16078667

Group type: EXPERIMENTAL
Intervention: Bilateral kidney transplantation with bilateral external iliac arteries anastomosed to the donors' renal arteries (Group A)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Unilateral external iliac arteries and the other internal iliac arteries anastomosed to the donors' renal arteries (Group B)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Internal iliac arteries anastomosed to the donors' renal arteries (Group C)
Number of subjects: 30
Study: 12355035

Group type: EXPERIMENTAL
Intervention: Clopidogrel therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intravenous blockade of the glycoprotein IIb/IIIa receptor
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Invasive approach
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clopidogrel treatment duration
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Choice of glycoprotein IIb/IIIa inhibitor
Number of subjects: 0
Study: 9801015

Group type: EXPERIMENTAL
Intervention: Serum levels of phospholipid dihomogammalinolenic acid (20:3)
Number of subjects: 323

Group type: EXPERIMENTAL
Intervention: Dietary cholesterol intake
Number of subjects: 323

Group type: EXPERIMENTAL
Intervention: Increased dietary intake or serum levels of polyunsaturated fatty acids
Number of subjects: 323
Study: 7642758

Group type: EXPERIMENTAL
Intervention: Fear of Spiders Questionnaire (FSQ)
Number of subjects: 338

Group type: COMPARATOR
Intervention: Non-treatment control groups
Number of subjects: 338

Group type: EXPERIMENTAL
Intervention: Factor analysis of FSQ
Number of subjects: 338
Study: 2694315

Group type: EXPERIMENTAL
Intervention: 100 mcg/kg of ivermectin
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: 150 mcg/kg of ivermectin
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: 200 mcg/kg of ivermectin
Number of subjects: 198

Group type: COMPARATOR
Intervention: Placebo capsules
Number of subjects: 198
Study: 688164

Group type: EXPERIMENTAL
Intervention: Questionnaires
Number of subjects: 1500
Study: 31848837

Group type: EXPERIMENTAL
Intervention: Gambling labels (problem gambling, pathological gambling, gambling disorder, gambling addiction)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alcohol use disorder
Number of subjects: 0

Group type: COMPARATOR
Intervention: Depression, obsessive-compulsive disorder, asthma
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Compulsive buying disorder
Number of subjects: 0
Study: 30990591

Group type: EXPERIMENTAL
Intervention: Sobriety incentives
Number of subjects: 229
Study: 29630646

Group type: EXPERIMENTAL
Intervention: Procedure 2 (NGS)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Procedure 1 (Pre-procedural scan)
Number of subjects: 24
Study: 26913766

Group type: EXPERIMENTAL
Intervention: Platelet-Rich Plasma
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Corticosteroid
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 25917009

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT-I) combined with Cognitive Behavioral Therapy for Depression (CBT-D)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Sleep Hygiene (SH) control condition combined with Cognitive Behavioral Therapy for Depression (CBT-D)
Number of subjects: 41
Study: 22797748

Group type: EXPERIMENTAL
Intervention: Hepatitis Health Promotion (HHP) group
Number of subjects: 156

Group type: COMPARATOR
Intervention: Art Messaging (AM) group
Number of subjects: 156
Study: 20940691

Group type: EXPERIMENTAL
Intervention: Serenoa repens (Permixon®) 320 mg daily for two months prior to surgery (G1)
Number of subjects: 144
Study: 17557211

Group type: EXPERIMENTAL
Intervention: Telephone-based pharmacy advisory service
Number of subjects: 500
Study: 16637758

Group type: EXPERIMENTAL
Intervention: Socially generated emotions (comedy, bereavement)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Nonsocially generated emotions (pizza scenes, wounded bodies)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Nonsocially generated emotions
Number of subjects: 4

Group type: COMPARATOR
Intervention: Social/nonsocial dimension
Number of subjects: 4
Study: 12907984

Group type: EXPERIMENTAL
Intervention: CosmoPost
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Composipost Aestheti‐Plus
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Composipost Light‐Post
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Para Post Fiber White
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional gold alloy posts (control)
Number of subjects: 0
Study: 10715308

Group type: EXPERIMENTAL
Intervention: Tirapazamine plus cisplatin (390 mg/m2 infused over 2 hours followed 1 hour later by cisplatin 75 mg/m2 over 1 hour, every 3 weeks for a maximum of eight cycles)
Number of subjects: 446

Group type: COMPARATOR
Intervention: Cisplatin alone (75 mg/m2, every 3 weeks for a maximum of eight cycles)
Number of subjects: 446
Study: 10369643

Group type: EXPERIMENTAL
Intervention: Platelet Sequestration (PSQ)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (CTR)
Number of subjects: 60
Study: 1539786

Group type: EXPERIMENTAL
Intervention: Ketorolac
Number of subjects: 72

Group type: COMPARATOR
Intervention: Papaveretum followed by paracetamol plus dextropropoxyphene orally
Number of subjects: 72

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 72
Study: 3904205

Group type: EXPERIMENTAL
Intervention: Chemoradiation therapy
Number of subjects: 76

Group type: COMPARATOR
Intervention: Radiation treatment alone
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Gamma therapy with total focal dose of 90-120 Gy
Number of subjects: 76
Study: 30430221

Group type: EXPERIMENTAL
Intervention: Medial femoral epicondyle upsliding osteotomy with PS arthroplasty (group A)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Constrained arthroplasty (group B)
Number of subjects: 53
Study: 29175357

Group type: EXPERIMENTAL
Intervention: Low dose sodium nitrite (1 or 9.6mg)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Low dose sodium nitrite (9.6mg)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 25648345

Group type: EXPERIMENTAL
Intervention: Block periodization (BP)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Traditional training organization (TRAD)
Number of subjects: 19
Study: 26460661

Group type: EXPERIMENTAL
Intervention: Same-admission cholecystectomy
Number of subjects: 266

Group type: COMPARATOR
Intervention: Interval cholecystectomy
Number of subjects: 266
Study: 23194211

Group type: EXPERIMENTAL
Intervention: Volume-controlled ventilation with I:E ratio of 1:1
Number of subjects: 56

Group type: COMPARATOR
Intervention: Volume-controlled ventilation with I:E ratio of 1:2
Number of subjects: 56
Study: 20130401

Group type: EXPERIMENTAL
Intervention: Early Mobilisation (EM)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Automated Monitoring (AM)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Standard Stroke Unit Care
Number of subjects: 32

Group type: COMPARATOR
Intervention: Combined EM and AM
Number of subjects: 32
Study: 18518697

Group type: EXPERIMENTAL
Intervention: CMTBI group (32 patients)
Number of subjects: 80

Group type: COMPARATOR
Intervention: MTBI group (48 patients)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: CMTBI group (among patients with mild or no extracranial injury)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: CMTBI group (among patients without preinjury ADHD)
Number of subjects: 80
Study: 16000283

Group type: EXPERIMENTAL
Intervention: 18F‐FDG PET after the first cycle of chemotherapy
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 18F‐FDG PET after the second cycle of chemotherapy
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 18F‐FDG PET for nonresponding lesions after the first cycle of chemotherapy
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 18F‐FDG PET for nonresponding lesions after the second cycle of chemotherapy
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Overall survival in responders
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Overall survival in nonresponders
Number of subjects: 11
Study: 12432319

Group type: EXPERIMENTAL
Intervention: Opioid analgesics pro re nata (as needed)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Regularly scheduled opioid analgesics
Number of subjects: 31
Study: 9872816

Group type: EXPERIMENTAL
Intervention: Type A hypopnea scoring criteria (>= 4% decrease in oxygen saturation)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Type B hypopnea scoring criteria (either a >= 4% decrease in SaO2 or an arousal)
Number of subjects: 94
Study: 8565248

Group type: EXPERIMENTAL
Intervention: Chinese herbal therapy (group 1)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo (group 2)
Number of subjects: 31
Study: 2963534

Group type: EXPERIMENTAL
Intervention: Methotrexate and 5 fluorouracil (MTX‐FU)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Methyl CCNU, vincristine, FU, and streptozotocin (MOF‐Strep)
Number of subjects: 34
Study: 30337757

Group type: EXPERIMENTAL
Intervention: Fluoride releasing flowable resin
Number of subjects: 76

Group type: COMPARATOR
Intervention: Conventional fissure sealant
Number of subjects: 76
Study: 27927736

Group type: EXPERIMENTAL
Intervention: Aripiprazole once-monthly 400 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Paliperidone palmitate
Number of subjects: 0
Study: 25502841

Group type: EXPERIMENTAL
Intervention: Remimazolam (0.10 mg/kg)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Remimazolam (0.15 mg/kg)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Remimazolam (0.20 mg/kg)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Midazolam (0.075 mg/kg)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Remimazolam (all doses)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Midazolam
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Remimazolam and Midazolam
Number of subjects: 75
Study: 23554134

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 68
Study: 21364151

Group type: EXPERIMENTAL
Intervention: Paclitaxel-eluting stents (PES)
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stents (SES)
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Zotarolimus-eluting stents (ZES)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Angiographic restenosis
Number of subjects: 162
Study: 18507183

Group type: EXPERIMENTAL
Intervention: Artificial sylvinite speleotherapy
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: General chloride sodium baths
Number of subjects: 120
Study: 21227735

Group type: EXPERIMENTAL
Intervention: 2 weekly replacement lenses
Number of subjects: 1432

Group type: COMPARATOR
Intervention: Monthly replacement lenses
Number of subjects: 1432

Group type: EXPERIMENTAL
Intervention: Lens storage case cleaning frequency
Number of subjects: 1432

Group type: EXPERIMENTAL
Intervention: Lens storage case replacement frequency
Number of subjects: 1432

Group type: EXPERIMENTAL
Intervention: Lens case cleaning method
Number of subjects: 1432
Study: 16118078

Group type: EXPERIMENTAL
Intervention: Team instructed physiotherapy (12 sessions of 60 min, two sessions a week, starting between the sixth and eighth postoperative week)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Team instructed physiotherapy (12 sessions of 60 min, two sessions a week, starting at the 26th postoperative week)
Number of subjects: 139
Study: 12390609

Group type: EXPERIMENTAL
Intervention: Multidisciplinary management program (neurologist and physical therapist intake and discharge, 18 group-supervised exercise therapy sessions, 2 group stress management and relaxation therapy lectures, 1 group dietary lecture, and 2 massage therapy sessions)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standard care with the patient's family physician
Number of subjects: 80
Study: 9749162

Group type: EXPERIMENTAL
Intervention: DBP target < 90 mmHg
Number of subjects: 18790

Group type: EXPERIMENTAL
Intervention: DBP target < 85 mmHg
Number of subjects: 18790

Group type: EXPERIMENTAL
Intervention: DBP target < 80 mmHg
Number of subjects: 18790

Group type: EXPERIMENTAL
Intervention: Felodipine treatment
Number of subjects: 18790

Group type: EXPERIMENTAL
Intervention: Additional prescription of beta-blocker
Number of subjects: 18790

Group type: EXPERIMENTAL
Intervention: Additional prescription of ACE-inhibitor
Number of subjects: 18790

Group type: EXPERIMENTAL
Intervention: Side-effects rate
Number of subjects: 18790

Group type: EXPERIMENTAL
Intervention: Ankle edema
Number of subjects: 18790
Study: 8156459

Group type: EXPERIMENTAL
Intervention: Spiramycin, 1,500,000 international units, twice per day (IU, bid) for 14 days
Number of subjects: 193

Group type: COMPARATOR
Intervention: Placebo capsule (visually identical)
Number of subjects: 193
Study: 2459514

Group type: EXPERIMENTAL
Intervention: Ketanserin (40 mg once or twice daily)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ritanserin (10 mg twice daily)
Number of subjects: 0
Study: 12392830

Group type: EXPERIMENTAL
Intervention: Valsartan
Number of subjects: 366

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 366
Study: 30091976

Group type: EXPERIMENTAL
Intervention: HbA1c testing for T2DM
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Age as a risk factor
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Gender and BMI as risk factors
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Historical comparison
Number of subjects: 400
Study: 26572551

Group type: EXPERIMENTAL
Intervention: Cognitive training (group sessions)
Number of subjects: 653

Group type: EXPERIMENTAL
Intervention: Reminiscence therapy (group sessions)
Number of subjects: 653

Group type: EXPERIMENTAL
Intervention: Individualized cognitive rehabilitation program (individual sessions)
Number of subjects: 653

Group type: COMPARATOR
Intervention: Usual care (reference group)
Number of subjects: 653
Study: 25216143

Group type: EXPERIMENTAL
Intervention: Implants placed level with the buccal crest (Group 0)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Implants placed 1 mm apical to the buccal aspect of the alveolar crest (Group 1)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Implants placed 2 mm apical to the buccal aspect of the alveolar crest (Group 2)
Number of subjects: 30
Study: 23243973

Group type: EXPERIMENTAL
Intervention: NovaMin without fluoride (Group A)
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: NovaMin with fluoride (Group B)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Standard prophylaxis paste without fluoride (Group C)
Number of subjects: 139
Study: 21035616

Group type: EXPERIMENTAL
Intervention: PMT-P (11 practitioner-assisted group sessions)
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: PMT-S (single instructional workshop followed by self-administration)
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: PMT-P
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: PMT-S
Number of subjects: 159

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 159
Study: 18586578

Group type: EXPERIMENTAL
Intervention: Nutritional counseling and calcium and vitamin D supplementation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 16091137

Group type: EXPERIMENTAL
Intervention: Hand written signature on covering letter
Number of subjects: 3799

Group type: COMPARATOR
Intervention: Scanned and printed signature on covering letter
Number of subjects: 3799

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 3799
Study: 12142585

Group type: EXPERIMENTAL
Intervention: 12-week in-hospital physical rehabilitation program supplemented with an exercise-training program (REX, n = 17)
Number of subjects: 31

Group type: COMPARATOR
Intervention: 12-week home-based physical rehabilitation program without exercise (R, n = 14)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Healthy controls, nonburn children (NB) aged 7 to <18 (n = 20)
Number of subjects: 31
Study: 10206081

Group type: EXPERIMENTAL
Intervention: MPV-2213ad 0.3 mg
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: MPV-2213ad 3 mg
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: MPV-2213ad 100 mg
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: MPV-2213ad
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 7794784

Group type: EXPERIMENTAL
Intervention: Cold exposure at 5 degrees C
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group at 28 degrees C
Number of subjects: 30
Study: 2221411

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 20

Group type: COMPARATOR
Intervention: Thiopental/halothane
Number of subjects: 20
Study: 729626

Group type: EXPERIMENTAL
Intervention: Indoramin 50 mg t.i.d.
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 31138224

Group type: EXPERIMENTAL
Intervention: Duloxetine 30/60 mg once daily (QD)
Number of subjects: 184

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Duloxetine 30/60 mg QD
Number of subjects: 184
Study: 27485006

Group type: EXPERIMENTAL
Intervention: Sodium Bicarbonate (SB)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: N-Acetyl-Cysteine (NAC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 25380326

Group type: EXPERIMENTAL
Intervention: CO2 angiography-guided endovascular therapy (EVT)
Number of subjects: 98
Study: 23519763

Group type: EXPERIMENTAL
Intervention: Heavy load (HL; 70% 1RM) resistance exercise
Number of subjects: 0

Group type: COMPARATOR
Intervention: Light load (LL; 16% 1RM) resistance exercise
Number of subjects: 0
Study: 21617451

Group type: EXPERIMENTAL
Intervention: Fat grafting enriched with platelet-rich plasma at 10 percent (group A)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Coleman fat grafting alone (group B)
Number of subjects: 42
Study: 19436039

Group type: EXPERIMENTAL
Intervention: Nicotine
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20